Certificate of Completion

The Certificate of Completion program provides attendees with a marketable certificate within a specific category of interest.  This certificate provides concise documentation of continuing education for attendees who are required to provide documentation to renew their qualifications.  Additionally, this certificate will provide attendees with practical, applicable skill documentation that can be used to enhance marketability within your organization.  

Certificates are offered in three areas: Immunohistochemistry, Imaging & Analysis and Laboratory Operations. To receive a Certificate of Completion, attendees must accrue a minimum of 9.0 credit hours in one of the three areas by attending the workshops designated below.  

Qualifying attendees automatically receive the certificate via mail to the address listed on their registration.  Certificates typically mail 8 weeks following the Convention.

Imaging & Analysis

  • Histology's Digital Transformation: Glass to Pixel
  • A Primer on Digital Pathology, Image Analysis and Artificial Intelligence: A Pathologist's Perspective
  • From Fixative to Spreadsheet: The Histology Process and Image Analysis
  • Validation & Analysis of Highly Multiplexed IHC by Digital Pathology
  • Image Analysis in the Histopathology Lab
  • Multiplex IF Staining and Image Analysis in Immune Oncology
  • Implementing A Digital Pathology Solution-What The Heck Did I Get Myself Into?
  • Multiplexed IF Techniques for the Interrogation of Complex Biology Within Intact Tissue Samples
  • Stereo... Huh?  The Why, What, and When of Stereology
  • Cryo-Fluorescence Tomography: A Technique To Bridge Multi-Resolution Multi-Modal Assays
  • Real Time Telepathology: The Intraoperative Future
  • Advances In Molecular Imaging: How Will They Affect Medicine Including Pathology

Laboratory Operations


  • A Spin on Ergonomics: Yoga for the Histotechnologist

  • The Leader and The Beanstalk: Growing Your Team Through Mentoring

  • When Is Quality Control not Quality Assurance?

  • The Next Gen Lab: New Technologies Coming to Pathology and How to Prepare

  • Oh, The Answers You Will Find In Your SDS!

  • A Quality Culture: Stop Fighting and Start Building From the Grass Roots

  • Safe Handling of CJD and Prions in the Histology Laboratory

  • Prevention of Medical Errors: The Role of Anatomic Pathology Labs in Providing Quality Patient Care

  • Implementation of the ISO 15189 Quality Management System

  • Making Safety Stick- Safety Culture in the Histology Laboratory

  • Laboratory Waste Management- The Latest Regulations

  • Achieving Quality and GLP Compliance in the Histopathology Laboratory

  • Standardization/Consolidation Across Multiple Sites

  • Business Math For Laboratory Management

  • The Cost of Reprocessing

  • Performing a Root Cause Analysis (RCA) in the Histology Laboratory

  • Ergonomics in the Laboratory

  • Getting the Most From Your Barcode Capabilities

  • Quality Assurance: What It Means For Your Laboratory

  • Grow Your Own Histologist


  • Antibody Panels

  • Mass Spectrometry Immunohistochemistry: Next Generation IHC

  • A Look Into the Current PD-L1 Landscape and To the Journey Ahead

  • Immunohistochemistry in a Research Setting

  • Fluorescent Methods for Alkaline Phosphatase-based Signal Detection
  • Why Fixation Matters in Diagnostic Immunohistochemistry

  • The Antibody Crisis: What Led Us Here and What Can We Do

  • Unlocking More Information From a Single 4 Micron Section

  • CUP - What Is It And How You Can Help Solve The Mystery

  • Troubleshooting IHC Based on Microscopic Findings

  • Meaning of the Markers - IHC Case Studies

  • The Pathologic Assessment of Grade, Stage, and Biomaker Status in Breast Carcinoma

  • Troubleshooting IHC Testing

  • Making Antibodies Great Again: Insight from an Antibody Manufacturer

  • Multiplex IF Using DNA Barcoded Primary Antibodies & Complementary Flurophore-Labeled Probes: Alignment of PD-L1 & PD-1 Biomarker Panels with True Reference H&E

  • Tissue is the Issue

  • “Are We There (Done) Yet?”  Validation of a New IHC platform

  • Application of Molecular Pathology for Immunophenotyping Non-human Primates

  • Importance of Controls in IHC Clinical Assay

  • Personalized Medicine: From Histology to NGS

  • MOHS Immunohistochemical Staining by Hand

  • Basic IHC: Understanding The Process to Improve Your Results

  • Carcinomas: Why Are They SO Popular

  • Principles of In Situ Hybridization

  • The Amazing Cell: Focus on IHC

  • The Basics of Titration Calculations and Protocol Development for IHC Staining

  •  Are Cluster Of Differentiation (CD) IHCs Cluttering Your Bench?

  • The Brains of This Operation: Special Considerations for IHC on CNS Tissue

  • Are You Ready to Accept the Challenge of Validating Cutting Edge Technology and Need a Starting Point?Does RNA-ISH Seem Complicated and Overwhelming?

  • Multiplex Immunohistochemistry Assays: Best Practices, Techniques, and Troubleshooting

  • IHC and ISH in a Veterinary Histology Lab

  • Microscopic Interpretation of Immuno-Stained Slides in the Context of Initial Procedure Validation and Ongoing Quality Control

  • Immunohistochemical And Histochemical Characterization Of Human Airway Air-Liquid-Interface Tissue Cultures

  • Use of the More Esoteric Antibodies in Immunohistochemistry

  • The Long And Winding Road To IHC Optimization

  • Understanding The Microsatellite Instability (MSI) Panel


Back to Top